JP2024522943A5 - - Google Patents
Info
- Publication number
- JP2024522943A5 JP2024522943A5 JP2024520657A JP2024520657A JP2024522943A5 JP 2024522943 A5 JP2024522943 A5 JP 2024522943A5 JP 2024520657 A JP2024520657 A JP 2024520657A JP 2024520657 A JP2024520657 A JP 2024520657A JP 2024522943 A5 JP2024522943 A5 JP 2024522943A5
- Authority
- JP
- Japan
- Prior art keywords
- tuberine
- nucleic acid
- seq
- amino acid
- acid molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163210456P | 2021-06-14 | 2021-06-14 | |
| US63/210,456 | 2021-06-14 | ||
| PCT/US2022/033452 WO2022266113A1 (en) | 2021-06-14 | 2022-06-14 | Gene therapy for tuberous sclerosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024522943A JP2024522943A (ja) | 2024-06-21 |
| JP2024522943A5 true JP2024522943A5 (cg-RX-API-DMAC7.html) | 2026-03-16 |
Family
ID=83080777
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024520657A Pending JP2024522943A (ja) | 2021-06-14 | 2022-06-14 | 結節性硬化症に対する遺伝子療法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240261439A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4355766A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024522943A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117715928A (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023026258A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3223219A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022266113A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116875636A (zh) * | 2023-07-05 | 2023-10-13 | 四川大学华西医院 | 胶原靶向的干细胞源外泌体的构建方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5478745A (en) | 1992-12-04 | 1995-12-26 | University Of Pittsburgh | Recombinant viral vector system |
| US6001650A (en) | 1995-08-03 | 1999-12-14 | Avigen, Inc. | High-efficiency wild-type-free AAV helper functions |
| US6156303A (en) | 1997-06-11 | 2000-12-05 | University Of Washington | Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom |
| US6136597A (en) | 1997-09-18 | 2000-10-24 | The Salk Institute For Biological Studies | RNA export element |
| WO2004058166A2 (en) | 2002-12-23 | 2004-07-15 | Vical Incorporated | Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection |
| US7561972B1 (en) | 2008-06-06 | 2009-07-14 | Dna Twopointo, Inc. | Synthetic nucleic acids for expression of encoded proteins |
| US7561973B1 (en) | 2008-07-31 | 2009-07-14 | Dna Twopointo, Inc. | Methods for determining properties that affect an expression property value of polynucleotides in an expression system |
| US11958887B2 (en) | 2017-05-17 | 2024-04-16 | The General Hospital Corporation | Gene therapy for tuberous sclerosis |
-
2022
- 2022-06-14 EP EP22760803.1A patent/EP4355766A1/en active Pending
- 2022-06-14 US US18/570,040 patent/US20240261439A1/en active Pending
- 2022-06-14 WO PCT/US2022/033452 patent/WO2022266113A1/en not_active Ceased
- 2022-06-14 CN CN202280050778.6A patent/CN117715928A/zh active Pending
- 2022-06-14 JP JP2024520657A patent/JP2024522943A/ja active Pending
- 2022-06-14 CA CA3223219A patent/CA3223219A1/en active Pending
- 2022-06-14 BR BR112023026258A patent/BR112023026258A2/pt unknown